Showing 1 - 10 of 12
Persistent link: https://www.econbiz.de/10009376047
Persistent link: https://www.econbiz.de/10010353470
Persistent link: https://www.econbiz.de/10010388964
Persistent link: https://www.econbiz.de/10009559970
Persistent link: https://www.econbiz.de/10009295731
Persistent link: https://www.econbiz.de/10010497611
Persistent link: https://www.econbiz.de/10011539516
Pharmaceutical markets experience the entry of numerous generic firms upon expiration of the brand firm's patent. In this paper, we take a close look at competition among the generic entrants during the first three years after patent expiration and examine whether there is a first mover...
Persistent link: https://www.econbiz.de/10012709667
The practice of detailing in the marketing of prescription drugs is undergoing significant changes. For instance, in September 2013, the Physician Payment Sunshine Act went into full effect. The accompanying transparency requirements have prompted physician practices and hospitals to severely...
Persistent link: https://www.econbiz.de/10014038374
Different objectives such as category demand expansion or market share stealing warrant the use of different marketing instruments. To help brand managers make informed decisions, it is essential that marketing mix models appropriately measure their effects. Random Utility Models (RUM) that have...
Persistent link: https://www.econbiz.de/10014042688